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Abstract
Dysregulated expression of the AGXT2L1 gene has been asso-
ciated to neuropsychiatric disorders. Recently the gene prod-
uct was shown to possess O-phosphoethanolamine phospho-
lyase activity. We here analyze the specificity of AGXT2L1 in
terms of both reaction and substrate. We show that the
enzyme, despite having evolved from a transaminase ances-
tor, is at least 500-fold more active as a lyase than as an ami-
notransferase. Furthermore, the lyase reaction is very
selective for O-phosphoethanolamine, strongly discriminating
against closely related compounds, and we dissect the factors
that contribute to such narrow substrate specificity. Overall,
AGXT2L1 function appears to be rigidly confined to phospho-
lipid metabolism, which is altered in neuropsychiatric distur-
bances. VC 2013 IUBMB Life, 65(7):645–650, 2013
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Introduction
Although enzymes are often described as exquisitely specific,
both in terms of reaction catalyzed and of substrates recog-
nized, this is not the rule. Today it is well appreciated that a
substantial fraction of metabolic enzymes are promiscuous,
meaning that they can catalyze reactions of different types and
with different substrates (1,2). In particular, enzymes depend-
ent on the cofactor pyridoxal 50-phosphate (PLP) are
considered prototypical promiscuous catalysts, due to the
intrinsic versatility of PLP (3,4). One pertinent example is ala-
nine-glyoxylate aminotransferase 2 (AGXT2), a mitochondrial
PLP-dependent enzyme that transaminates a variety of sub-
strates – such as L-alanine, 5-aminolevulinate (5-ALA), b-ala-
nine and D-3-aminoisobutyrate (5) – and also acts as a lyase
on L-cysteine conjugates (6) – a secondary activity possessed
by several aminotransferases (7).
AGXT2L1 is a brain enzyme, so-named after its similarity
to AGXT2 (36% sequence identity), that may be involved in the
pathogenesis of severe neuropsychiatric disturbances. For
example, in a study designed to pinpoint common gene expres-
sion profiles between schizophrenia and bipolar disorder, the
AGXT2L1 gene was the most consistently upregulated in the
brains of deceased patients with either condition, as compared
to control subjects (8). Such an increased expression might con-
tribute to the diseases or represent a compensatory response to
some prior neurochemical imbalance. Potentially consistent
with this latter possibility was the finding that, in mouse brain,
AGXT2L1 was the most upregulated gene following treatment
with the mood-stabilizer lithium carbonate (9). All these find-
ings elicited a considerable interest on AGXT2L1, but for a long
time the function of the encoded protein remained obscure.
Recently, Veiga-da-Cunha and coworkers (10) demon-
strated in an elegant study that AGXT2L1 is a lyase acting on
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O-phosphoethanolamine (PEA). In other words, they showed
that the enzyme irreversibly degrades PEA to acetaldehyde,
phosphate and ammonia (Fig. 1A) (10–13), also providing a
limited characterization of this activity. While this result was
remarkable, it left several questions unanswered.
First, the reported catalytic efficiency of the PEA phospho-
lyase reaction was modest, raising doubts that perhaps
other metabolites could be better substrates of AGXT2L1.
Furthermore, it remained unclear whether the enzyme showed
reaction promiscuity (like its relative AGXT2) and could for
example act as a transaminase towards some substrate, con-
tributing to different metabolic pathways. More generally, it
was not known whether AGXT2L1 would bind other common
amino compounds, which might function as modulators, as
reported for other brain-specific PLP-dependent enzymes (14).
Addressing these and similar questions seemed important to
better understand AGXT2L1 as a catalyst and to shed more
light on its actual biological role.
Herein, we explore the reaction and substrate selectivity of
AGXT2L1, showing that the enzyme is strikingly specific and non-
promiscuous. We discuss the implications of these findings for
the evolution, mechanism and metabolic function of AGXT2L1.
Experimental Procedures
Materials and methods used in this work are provided as
Supporting Information.
Results
Efficiency and Specificity of the Lyase Reaction
Catalyzed by AGXT2L1
We characterized the activity of recombinant AGXT2L1
towards PEA. At the optimal pH 8.0, the observed kinetic
parameters were: K PEAM ¼ 0:9 mM, kPEAcat ¼ 2:3 sec1 andðkcat=KMÞPEA ¼ 2;600M1 sec1 (Fig. 1B). These values are close to
those reported by Veiga-da-Cunha et al (10), who performed
their experiments at pH 7.4. The K PEAM value was also very sim-
ilar to that reported over 40 years ago by Fleshood and Pitot
for a partially purified PEA phospho-lyase from rabbit (13).
Tests on a dozen commercially available PEA analogs
showed that the lyase activity of AGXT2L1 is extremely sub-
strate-specific (Supporting Information Table 1). When the
phosphate moiety of PEA was replaced by other good leaving
groups, such as bromine or a thiol, the elimination reaction
was virtually undetectable. A carboxylate adjacent to the
amino carbon (as in O-phosphoserine) or a glycerol moiety
attached to the phosphate (as in glycerophosphoethanolamine)
also drastically prevented activity.
We studied in detail the reaction of AGXT2L1 with O-sul-
foethanolamine (SEA), a PEA analog containing a sulfate
(rather than phosphate) leaving group. Despite its close struc-
tural similarity to PEA, SEA reacted very poorly. Its specificity
constant, ðkcat=KMÞSEA, was 1.4 M1 sec1, or 1,800-fold lower
than ðkcat=KMÞPEA. While the SEA elimination rate did not reach
saturation even at 300 mM substrate (Fig. 1B), preventing
determination of accurate individual values for kSEAcat and K SEAM ,
most of the discrimination against SEA clearly mirrored a very
high KM for this compound. The kcat=KM gap between PEA and
SEA did not change much in the pH 6–9 range (Supporting
Information Fig. 1).
(A) The PEA phospho-lyase reaction (12,13) catalyzed
by recombinant AGXT2L1 (10,11). (B) Rate of the
elimination reaction as a function of the concentra-
tion of PEA (*, l) or SEA (!) at 30C, pH 8.0. Fitting
of the PEA data points to the Michaelis–Menten
equation yielded KPEAM ¼ 0:9 6 0.2 mM and
Vmax ¼ 2:4 6 0:2lMoles=min permg of protein (cor-
responding to kSEAcat ¼ 2:3 sec1). As the SEA elimina-
tion rate did not reach saturation even at the highest
substrate concentration tested, reliable values of
kSEAcat and K
SEA
M could not be determined by data fit-
ting. However, ðkcat=KMÞSEA, representing the initial
slope of the Michaelis–Menten hyperbola, was 1.4 6
0.3 M1 sec1. (C) Inhibitory effect of various anions
on the rate of the PEA elimination reaction, pH 8.
PEA concentration was 1 mM. The data points refer
to phosphate (*), sulfate (l), glyoxylate (&), methyl
sulfate (n) and SEA (~). Calculated Ki values are
given in Supporting Information Table 2.
FIG 1
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Relatively Unspecific Inhibition of AGXT2L1 by Anions
The strict substrate specificity of AGXT2L1 contrasted with its
facile inhibition by a variety of anionic compounds. In addition
to the reported competitive inhibition of AGXT2L1 by phos-
phate (10), we observed a very similar inhibition by other inor-
ganic anions such phosphite and sulfate (Fig. 1C; Supporting
Information Table 2). Methyl sulfate was one order of magni-
tude less effective than sulfate, while SEA inhibited very
weakly. Glyoxylate and to a lesser extent pyruvate were also
inhibitors (Fig. 1C; Supporting Information Table 2).
Spectroscopic Screening of AGXT2L1 Binding
Selectivity
In PLP-dependent enzymes, cofactor absorption is often
exploited to monitor the binding of ligands and the formation
of catalytic intermediates (e.g., 15, 16). For example in amino-
transferases, reaction with an amino group donor substrate in
the absence of amino group acceptors leads to a half-transa-
mination, that is, the conversion of PLP (kmax  410 nm) to
pyridoxamine 50-phosphate (PMP; kmax  330 nm).
The reaction of AGXT2L1 with PEA was accompanied by
significant changes in the cofactor spectrum, which we tenta-
tively attributed to the formation of a Schiff base with the
amine (Supporting Information Fig. 2). We also screened spec-
troscopically the interaction of AGXT2L1 with 70 other
amino compounds (Supporting Information Table 2), to identify
possible additional ligands. Our test set tried to include the
most common amino metabolites (especially amino acids and
brain amines) as well as compounds sufficiently diverse in
terms of chemical properties (anionic, cationic, aromatic etc.),
to gather information on the binding selectivity of AGXT2L1.
The results of this screening can be summarized as follows.
i. The vast majority of compounds caused only negligible
spectral changes, implying their inability (at least at the 5
mM concentration used) to bind and react at the AGXT2L1
active site. Most of the compounds that did react were
x-amines, that is, carried a terminal amino group not
adjacent to a carboxylate.
ii. L-cysteine and related aminothiols gave rise to bands at
340 nm (Fig. 2A), attributable to thiazolidine adducts
formed with PLP (14). Aminothiols in fact behaved as time-
dependent inhibitors of AGXT2L1 (not shown), although in-
hibition was negligible at the concentrations of L-cysteine
typically found in the cytosol (0.1 mM; (17)).
iii. Reaction of AGXT2L1 with 5-ALA, a substrate of AGXT2
(5), produced a sharp band at 507 nm (Fig. 2A). This band
strongly resembled the peaks that, in other enzymes, are
attributed to stabilized carbanionic intermediates (quino-
noids), formed upon cleavage of one of the bonds connect-
ing the amino carbon to its substituents (18). Quinonoid
bands were formed by other compounds that, like 5-ALA,
bear a keto function adjacent to the amino group (e.g.,
2-aminoacetophenone).
(A) Absorption spectra of recombinant AGXT2L1 (9
lM) in 25 mM Bis-Tris propane, pH 8, 20 C, were
recorded in the absence of ligands (dotted line) and
upon reaction with 5 mM L-cysteine, or 5 mM 5-ALA
or 0.5 mM 2-aminoacetophenone. (B) Progressive
spectral changes observed in the presence of 5 mM
3-APP (pH 8, 20 C). Inset: time-course of the half-
transamination. (C) Dependence of kobs for the half-
transamination (PMP formation) on the concentration
of 3-APP (25 mM triethanolamine buffer, pH 8, 30C).
The solid line is a fit of the data to a hyperbolic func-
tion, yielding K0.5 ¼ 1.9 mM and an extrapolated
maximum kobs of 1.1  102 sec1. For comparison,
the half-transamination rates obtained at two concen-
trations of hypotaurine are also shown.
FIG 2
Schiroli et al. 647
iv. The only evidences for substantial PMP formation, and hence
for half-transamination, were obtained upon incubating the
enzyme with small, anionic x-amines such as taurine, hypo-
taurine and 3-APP. Even in these cases, accumulation of a
330-nm band took minutes to occur (Fig. 2B). Formation of
this species could be partially reversed by the addition of
pyruvate, glyoxylate or a-ketoglutarate (not shown).
Aminotransferase Activity of AGXT2L1
We studied in more detail the reaction of 3-APP, which differs
from PEA only for having the ester oxygen atom replaced by a
methylene group. This difference is expected to interfere with
the lyase reaction, which in fact was undetectable (Supporting
Information Table 1), but not necessarily with the transamina-
tion. Indeed, 3-APP formed PMP faster than any other amino
compound tested.
We monitored the reaction of 3-APP (0.1–10 mM) with
AGXT2L1 at 30C. At each 3-APP concentration, the data fit well
to a monoexponential process and the observed pseudo-first-
order rate constants increased hyperbolically as a function of
the amine concentration (Fig. 2C). The initial slope of the hyper-
bola (i.e., the apparent second-order rate constant for the half-
transamination) was 5.3 6 1.3 M1 sec1. This value represents
an upper limit of kcat=KM for a full transamination reaction,
which cannot proceed faster than its first half. Stated another
way, our data imply that the specificity constant for 3-APP
transamination (whatever the amino group acceptor) is going to
be 500-fold lower than ðkcat=KMÞPEA for the lyase reaction.
To buttress this conclusion, we assessed the actual amine-
pyruvate aminotransferase activity of AGXT2L1, by measuring
formation of the product L-alanine (19). Pyruvate was kept con-
stant at 20 mM, while 3-APP was used at concentrations up to
50 mM. In all these assays, the observed rate of 3-APP transa-
mination remained well below the limit expected based on the
half-transamination data (Supporting Information Fig. 3).
Discussion
Evolution of AGXT2L1: of an Aminotransferase a
Phospho-lyase Made
AGXT2L1 belongs to a subfamily of proteins termed ‘‘class II
aminotransferases’’ (20) that, as the name suggests, is com-
posed almost entirely by transaminases (Supporting Information
Fig. 4). This subfamily is not known to include any bona fide
lyase apart from AGXT2L1 (and the related protein AGXT2L2
(10)), strongly suggesting that the enzyme has evolved from an
aminotransferase ancestor. However, AGXT2L1 is at least 500-
fold more efficient as a phospho-lyase than as an aminotrans-
ferase, implying that evolution has led to both a new reaction
specificity and to a strongly limited catalytic promiscuity.
What modifications converted an ancestral aminotransfer-
ase into a (specific) phospho-lyase? Some insights may be
obtained by analyzing conservation at key active site positions
between AGXT2L1, AGXT2 and other related transaminases of
known structure, such as the bacterial GABA aminotransfer-
ase (GABA-AT; Supporting Information Table 3). A striking
change involves Ile50, which in GABA-AT provides a roof for
the substrate binding site and may help dictate reaction speci-
ficity. This aliphatic residue corresponds to Val110 in AGXT2
but has no obvious counterpart in AGXT2L1, suggesting sub-
stantial differences in the local structure. Another significant
change involves Arg398, which in GABA-AT binds the
a-carboxylate of the ketoacid substrate: this residue is con-
served in AGXT2, but mutated to a shorter Lys in AGXT2L1.
Determinants of Binding Selectivity in AGXT2L1
The specificity of AGXT2L1 for PEA as compared to structural
analogs can be mostly explained as binding selectivity. Our
data suggest that at least three factors may be enforcing such
selectivity. First, the enzyme clearly favors binding x-amines,
suggesting that the active site structure discriminates against
amino compounds that contain an a-carboxylate (e.g., O-phos-
pho-L-serine). Second, the size of the ligand is certainly a
factor and it is reasonable to assume that binding of bulky
PEA analogs such as glycerophosphoethanolamine (Supporting
Information Table 1) or O-phospho-5 hydroxy-L-lysine (10)
may be hampered due to steric hindrance. Finally, some ana-
logs that are smaller than PEA and potentially very reactive
(e.g., 2-bromoethylamine) may nevertheless bind poorly
because they lack an anionic function.
Indeed, our data imply the occurrence, in the AGXT2L1 active
site, of a subsite responsible for binding anionic groups. By itself
this subsite does not seem very selective, as a variety of anions, in
addition to phosphate, can act as competitive inhibitors. On the
other hand, the requirements for interacting with the subsite may
be stricter when it comes to binding anionic amines.
Consider in particular SEA. This compound is nearly isos-
teric with PEA, while free sulfate shows a Ki essentially identical
to phosphate. Nonetheless, ðkcat=KMÞSEA is 1,800-fold lower than
ðkcat=KMÞPEA and such a dramatic difference is mostly attributable
to weaker binding of SEA (Fig. 1B). The sulfate group in SEA
bears a single negative charge (rather than two like the phos-
phate group in PEA) but this explains only in part the observed
affinity gap; in fact, Ki for monoanionic methylsulfate is just 12-
fold higher than Ki for plain sulfate (Supporting Information Ta-
ble 2). Thus, an exceedingly large discrimination between phos-
phate and sulfate appears to occur when the two groups are
part of an anionic amine. One possibility is that binding of the
amine is accompanied by a conformational change that imparts
an increased selectivity to the anion subsite.
Support for a conformational change upon substrate bind-
ing comes from an analysis of K PEAM . There are indications that
this parameter can be considered an overall dissociation con-
stant of the substrate from AGXT2L1. If this is the case, K PEAM
should depend both on the interactions of PEA with the anion
subsite and on the formation of covalent intermediates with
PLP. However, the value of KPEAM is nearly identical to Ki for
inorganic phosphate, suggesting that the binding energy
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gained from covalently linking the amino group to PLP is
almost entirely used up to pay for some other unfavorable pro-
cess, possibly a rearrangement of the active site structure (21).
Considerations on the Biological Role of AGXT2L1
AGXT2L1 has been apparently shaped by evolution to maxi-
mize specificity and limit promiscuity, rather than to optimize
absolute catalytic performance (even though its catalytic pa-
rameters are comparable to those reported for other mamma-
lian phospho-lyases (10,22)). A recent study (1) has highlighted
three major conditions under which specific enzymes are met-
abolically preferred to promiscuous ones, namely i) when the
catalyzed reaction is essential, ii) when a high metabolic flux
is needed, and iii) when the enzyme activity must be tightly
regulated. The need for a strict regulation may be especially
relevant for AGXT2L1, whose reaction is irreversible and gen-
erates potentially toxic products.
When is AGXT2L1 activity effectively required? PEA is
both a product of sphingolipid degradation and a precursor of
glycerophospholipid biosynthesis (Supporting Information Fig.
5) and it can accumulate when membrane remodeling or deg-
radation increases. Such an accumulation may be undesirable
for several reasons – for example, it has been shown that PEA
and the parent compound ethanolamine interfere with mito-
chondrial function (23) – and under these circumstances
AGXT2L1 could function as a ‘relief valve’, to counteract the
rise in PEA concentration. PEA can be also degraded by spe-
cific phosphatases, but this reaction generates ethanolamine
and is easily reversed by ethanolamine kinase (Supporting In-
formation Fig. 5).
There is a vast literature associating neuropsychiatric dis-
orders to alterations in the brain levels of PEA and related
phosphomonoesters and in the membrane phospholipid metab-
olism (24 and references therein). In keeping with this associa-
tion, our findings confine the role of AGXT2L1 to phospholipid
metabolism. An increased expression of AGXT2L1 during
disease (8) might be primarily a compensatory mechanism to
alleviate the effects of, for example, excessive membrane
degradation. On the other hand, drawbacks of a prolonged
overproduction of AGXT2L1 may include a chronic exposition
of the cells to acetaldehyde and ammonia and an altered
homeostasis of sphingolipids and glycerophospholipids.
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